NuCana plc
NCNA·NasdaqCM·Healthcare
1.0200+0.0100 (+0.99%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market0.9902−0.0298 (−2.92%)
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close1.0100
Open1.0302
Day range0.98051.0870
52-week range0.94804.5500
Off day high−6.16%
Off 52-week high−77.58%
Volume10.83K
Avg. volume (3M)120.35K
Market cap4.25M
EPS (TTM)0.000000
Forward P/E-0.11
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.44
Shares outstanding4.16M
Short interest3.48% of float
Earnings dateAug 13, 2025 (est.)
Analyst target—
Profit margin0.00%
Against its peers
Compare in full ›| NCNA | PCSA | NFX.L | PMCB | RKV.V | TOVX | |
|---|---|---|---|---|---|---|
| Market cap | 4.25M | 5.41M | 2.87M | 4.09M | 4.27M | 8.72M |
| P/E (TTM) | — | — | — | — | — | 0.3 |
| Forward P/E | -0.1 | -0.5 | — | -1.0 | — | -1.0 |
| Price/book | 0.2 | -17.0 | 1.1 | 0.1 | -2.0 | 0.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −71.98% | −75.51% | −72.97% | −54.75% | +2.94% | −29.63% |
| Today | +0.99% | −0.26% | +10.00% | +12.03% | 0.00% | +4.40% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All NCNA news ›NuCana Wins Key European Patent for Lead Cancer Drug NUC-7738
Nucana ( (NCNA) ) just unveiled an announcement. NuCana plc, a clinical-stage biopharmaceutical company based in Edinburgh, develops cancer therapies using its proprietary ProTide technology to enhance existing nucleoside analog…
From the 4Search news index, newest first.
In the news
1mentions in 30 days
1with it in the headline
Negativesentiment
Mentioned with
People in the coverage
Most coverage from
- theglobeandmail.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.